Published DateClear

Start Date

End Date

Category

• Business2
• Pipeline1

Organizations

• Bausch + Lomb67
• Eyes On Eyecare53
• Alcon, Inc.47
• American Optometric Association38
• Harrow31
• Glaukos28
• Regeneron25
• Topcon Healthcare25
• Aldeyra Therapeutics21
• Sight Sciences19

Tags

• Cornea2
• Clinical Trials1
• Corneal Dystrophy1
• Finance1
• Leadership1
• Ocular Surface Disease1
• Research1
• Technology1

• Organizations: Brightstar Therapeutics✕

Clear all

Business

Leadership watch: Vital Tears, Brightstar form joint medical advisory board

We’ve got the latest on a newly-established board of clinical experts focused on novel solutions for OSD patients.

Pipeline

New findings support Brightstar Therapeutics' corneal allograft for LSCD

Pilot study investigates use of BrightMEM as an alternative form of corneal transplantation involving Descemet’s membrane.

Business

Brightstar Therapeutics secures financing for groundbreaking corneal disease treatment

Company plans to launch trials on its BrightMEM corneal allograft; appoints two new ophthalmologists to leadership positions.